Stocks · Healthcare · Medical - Instruments & Supplies
Embecta Corp. EMBC
$5.65 -2.42% Close, Oct 2, 2026 · NASDAQ · Market cap $335.2M
High qualityWeak trendInexpensive vs sector
Next earnings report: Nov 24, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned -61.6%, behind the S&P 500 by 76.7 percentage points.
- The shares trade at 3.8× trailing earnings, lower than 90% of the company's own readings over the past five years.
- The stock is 61% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 21%
- EPS growth (TTM, YoY)Bottom 45%
- FCF growth (TTM, YoY)Top 42%
- Revenue growth, 3-year CAGRBottom 20%
- Revenue growth accelerationBottom 28%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 6%
- Gross marginBottom 45%
- Operating marginTop 10%
- Cash conversion (OCF / net income)Top 31%
- Accruals (lower is better)Top 49%
- Net debt / EBITDA (lower is better)Bottom 16%
- Interest coverTop 35%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 1%
- Free-cash-flow yieldTop 1%
- EBITDA / enterprise valueTop 4%
- Sales / enterprise valueTop 19%
- P/E vs own 5-year history (lower is better)Top 25%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 3%
- 6-month returnBottom 12%
- 1-year return vs S&P 500Bottom 6%
- Distance from 52-week highBottom 14%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 33%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 1%
- Upside to consensus price targetBottom 5%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 22%
- Maximum drawdown, 3 yearsBottom 24%
- Beta vs S&P 500 (lower is better)Top 35%
- Net debt / EBITDA (lower is better)Bottom 16%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -3.4% | -7.6% | ↓ |
| EPS growth (YoY) | 113.9% | 4.4% | ↓ |
| Gross margin | 63.0% | 59.9% | ↓ |
| Operating margin | 26.8% | 24.8% | ↓ |
| FCF margin | 12.0% | 16.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -7.6% | -3.4% | ↓ | Bottom 21% |
| EPS growth (TTM, YoY) | 4.4% | 113.9% | ↓ | Bottom 45% |
| Gross margin | 59.9% | 63.0% | ↓ | Bottom 45% |
| Operating margin | 24.8% | 26.8% | ↓ | Top 10% |
| Net margin | 8.6% | 7.5% | ↑ | — |
| Free-cash-flow margin | 16.2% | 12.0% | ↑ | — |
| Return on invested capital | 17.8% | — | Top 6% | |
| Revenue growth, 3-year CAGR | -1.5% | — | Bottom 20% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.99×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -6.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +2.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 4.70×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 2.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 8.11%
- Net buyback yield (TTM)
- 2.33%
- Shareholder yield
- 10.44%
- Share count change, 1 year
- +0.0%
- Share count change, 3-year CAGR
- +0.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +13.1%
- Average 2-day reaction, last 8
- -1.4%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $5.00
- Target vs current price
- -11.5%
- Analysts with a rating
- 4
- Share rating Buy or Strong Buy
- 0%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 7, 2026 | +110.7% | +26.3% | +46.0% | +62.6% | — |
| May 5, 2026 | -35.7% | -57.8% | -63.7% | -62.3% | -60.4% |
| Feb 5, 2026 | +6.0% | -7.8% | -11.4% | -16.8% | -18.7% |
| Nov 25, 2025 | -28.6% | -7.2% | -16.0% | -18.6% | -27.8% |
| Aug 8, 2025 | +146.2% | +18.5% | +33.9% | +44.4% | +28.8% |
| May 9, 2025 | +6.1% | -10.0% | -12.3% | -26.4% | -25.4% |
| Feb 6, 2025 | +44.4% | -2.6% | -8.7% | -29.2% | -30.1% |
| Nov 26, 2024 | +25.0% | +29.8% | +41.8% | +40.7% | -7.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 7, 2026 | $0.56 | $0.27 | +110.7% | $271.7M |
| May 5, 2026 | $0.27 | $0.42 | -35.7% | $221.8M |
| Feb 5, 2026 | $0.71 | $0.67 | +6.0% | $261.2M |
| Nov 25, 2025 | $0.50 | $0.70 | -28.6% | $264.0M |
| Aug 8, 2025 | $1.12 | $0.46 | +146.2% | $295.5M |
| May 9, 2025 | $0.70 | $0.66 | +6.1% | $259.0M |
| Feb 6, 2025 | $0.65 | $0.45 | +44.4% | $261.9M |
| Nov 26, 2024 | $0.45 | $0.36 | +25.0% | $286.1M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 3.8× | 10.1× | 10th | Top 1% |
| P/E (forward) | 3.1× | — | — | — |
| EV / EBITDA | 5.9× | — | — | Top 4% |
| EV / Sales | 1.59× | — | — | Top 19% |
| Free-cash-flow yield | 49.10% | — | — | Top 1% |
| Earnings yield | 26.19% | — | — | Top 1% |
P/E over the past five years
Range 2.0× – 27.0× since Sep 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -61.6%
- Earnings per share growth (TTM)
- +4.4%
- Change in P/E multiple
- -65.5%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 54
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +21.3%
- 200-day average slope (20 days)
- -9.3%
- Distance from 50-day average
- +14.2%
- Distance from 200-day average
- -19.5%
- RSI (14)
- 57.8
- Relative volume
- 1.03×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 74.8%
- Volatility vs own 5-year history
- 86th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.87
- Correlation with S&P 500
- 0.17
- Current drawdown from 1-year high
- -61.4%
- Maximum drawdown, 3 years
- -86.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 22, 2022 | May 19, 2026 | -93.8% | 1043 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $335.2M
- P/E (TTM)
- 3.8
- EPS, diluted (TTM)
- $1.48
- Revenue (TTM)
- $1.02B
- Dividend yield
- 5.66%
- 52-week range
- $2.77 – $14.91
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.17B | $1.13B | $1.12B | $1.12B | $1.08B |
| Gross profit | $800.0M | $774.9M | $749.9M | $728.9M | $679.5M |
| Operating income | $492.0M | $378.1M | $229.6M | $174.2M | $329.3M |
| Net income | $414.8M | $223.6M | $70.4M | $78.3M | $95.4M |
| EPS (diluted) | $7.31 | $3.89 | $1.22 | $1.34 | $1.62 |
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $286.1M | $261.9M | $259.0M | $295.5M | $264.0M | $261.2M | $221.8M | $271.7M |
| Net income | $14.6M | -$700,000 | $23.5M | $45.5M | $26.4M | $44.1M | -$4.1M | $21.1M |
| EPS (diluted) | $0.25 | -$0.01 | $0.40 | $0.78 | $0.45 | $0.74 | -$0.07 | $0.36 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $456.0M | $412.2M | $67.7M | $35.7M | $191.7M |
| Capital expenditure | -$39.0M | -$24.0M | -$26.5M | -$15.8M | -$9.3M |
| Free cash flow | $417.0M | $388.2M | $41.2M | $19.9M | $182.4M |
| Dividends paid | $0 | -$8.6M | -$34.4M | -$34.5M | -$35.0M |
| Net share buybacks | $0 | $0 | -$3.6M | -$3.0M | -$5.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $214.7M
- Total assets
- $1.27B
- Total liabilities
- $1.88B
- Total debt
- $1.50B
- Net debt
- $1.29B
- Shareholders’ equity
- -$612.7M
As of Jun 30, 2026 (filed Aug 7, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 27, 2026 | $0.01 | Sep 15, 2026 |
| May 28, 2026 | $0.01 | Jun 15, 2026 |
| Feb 27, 2026 | $0.15 | Mar 17, 2026 |
| Dec 5, 2025 | $0.15 | Dec 18, 2025 |
| Aug 29, 2025 | $0.15 | Sep 15, 2025 |
| May 28, 2025 | $0.15 | Jun 13, 2025 |
| Feb 28, 2025 | $0.15 | Mar 14, 2025 |
| Dec 6, 2024 | $0.15 | Dec 18, 2024 |
Short interest
- Shares sold short
- 5,547,979
- Days to cover
- 4.46
- Change vs previous report
- -11.4%
FINRA short interest, settlement date Sep 15, 2026.